FDA Drug/Biologics Approval BLA 125156 S-114, RANIBIZUMAB

FDA Drug/Biologics Approval BLA 125156 S-114, RANIBIZUMAB

Regular price $149.00 USD
Regular price Sale price $149.00 USD
Sale Sold out
BLA 125156 S-114
Company: GENENTECH
Drug Name: LUCENTIS
Active Ingredients: RANIBIZUMAB
Strength: 6MG/ML
Dosage Form/Route: Injectable; Injection
Action Date: 06/30/2006
Marketing Status: Prescription
Submission Classification: ORIG-1

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details